Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
ο»Ώ

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > πŸ‘€ The Mayo Clinic has purchased a VMS+3.2 model πŸ“πŸš€
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1274)
•••
Comment by GrahamBon Nov 20, 2024 8:33am
24 Views
Post# 36321303

RE:RE:RE:πŸ‘€ The Mayo Clinic has purchased a VMS+3.2 model πŸ“πŸš€

RE:RE:RE:πŸ‘€ The Mayo Clinic has purchased a VMS+3.2 model πŸ“πŸš€Jopatchie,
'Your comments, and assumptions about me and my history are as wild and wildly wrong as you have been about this company.
Facts matter.
There have been virtually no sales.
The financing open for over 7 months still hasn't closed.
Not only are hospitals not buying this,but investors aren't supporting it.
The stock price keeps drifting lower, and adjusting for dilution is at all time lows!

Your excessive pumping on this company -almost unilaterally, is like shouting in a vacuum.
Its not working, and likely hurting the company .
Anyone that comes to this board and sees your emojis and ranting is likely scared away.
Its only you and your one supporter G1945 here.
Keep pumping pal
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities